CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

Clinical trial NCT02917083 · RECRUITING

Trial details

NCT number: NCT02917083
Sponsor: Baylor College of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin's Lymphoma Non-Hodgkin Lymphoma

Start date: 2017-05-08
Primary completion: 2027-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.